132 related articles for article (PubMed ID: 3028650)
1. Effects of inhibitors of C1q biosynthesis on macrophage Fc receptor subclass-mediated antibody-dependent cellular cytotoxicity and phagocytosis.
Mocharla R; Mocharla H; Leu RW
Cell Immunol; 1987 Mar; 105(1):127-35. PubMed ID: 3028650
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of C1q biosynthesis suppress activation of murine macrophages for both antibody-independent and antibody-dependent tumor cytotoxicity.
Leu RW; Zhou AQ; Shannon BJ; Herriott MJ
J Immunol; 1990 Mar; 144(6):2281-6. PubMed ID: 2107257
[TBL] [Abstract][Full Text] [Related]
3. Characterization of murine macrophage Fc receptor-dependent phagocytosis and antibody-dependent cellular cytotoxicity during in vitro culture with interferons-gamma, alpha/beta and/or fetal bovine serum.
Leu RW; Rummage JA; Horn MJ
Immunobiology; 1989 Feb; 178(4-5):340-50. PubMed ID: 2469639
[TBL] [Abstract][Full Text] [Related]
4. Exogenous C1q reconstitutes resident but not inflammatory mouse peritoneal macrophages for Fc receptor-dependent cellular cytotoxicity and phagocytosis. Relationship to endogenous C1q availability.
Leu RW; Zhou AQ; Rummage JA; Kennedy MJ; Shannon BJ
J Immunol; 1989 Nov; 143(10):3250-7. PubMed ID: 2809201
[TBL] [Abstract][Full Text] [Related]
5. Polyanions inhibit murine macrophage Fc receptor mediated ADCC and binding.
Mocharla R; Mocharla H; Leu RW
Immunol Invest; 1989 Jun; 18(5):689-96. PubMed ID: 2737700
[TBL] [Abstract][Full Text] [Related]
6. Exogenous C1q reconstitutes a secondary deficiency of C5-deficient AKR mouse macrophages for FcR-dependent cellular cytotoxicity and phagocytosis.
Leu RW; Zhou AQ; Kennedy MJ; Shannon BJ
J Immunol; 1991 Feb; 146(4):1233-9. PubMed ID: 1991965
[TBL] [Abstract][Full Text] [Related]
7. Relationship between murine macrophage Fc receptor-mediated phagocytic function and competency for activation for non-specific tumor cytotoxicity.
Leu RW; Rummage JA; Rahimi MB; Herriott MJ
Immunobiology; 1986 Apr; 171(3):220-33. PubMed ID: 3519439
[TBL] [Abstract][Full Text] [Related]
8. Modulation of FcR function by complement: subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages.
Bobak DA; Gaither TA; Frank MM; Tenner AJ
J Immunol; 1987 Feb; 138(4):1150-6. PubMed ID: 3492544
[TBL] [Abstract][Full Text] [Related]
9. Photometric assays for FcRI-dependent binding, phagocytosis, and antibody-dependent cellular cytotoxicity mediated by monomeric IgG gamma 2a in murine peritoneal macrophages.
Leu RW; Robinson CJ; Wiggins JA; Shannon BJ; Rummage JA; Horn MJ
J Immunol Methods; 1988 Oct; 113(2):269-78. PubMed ID: 2971739
[TBL] [Abstract][Full Text] [Related]
10. FcR-independent antibody-mediated cellular cytotoxicity.
Colsky AS; Mendez LE; Peacock JS
J Leukoc Biol; 1991 Jun; 49(6):548-55. PubMed ID: 2026962
[TBL] [Abstract][Full Text] [Related]
11. Evidence that C1q, a subcomponent of the first component of complement, is an Fc receptor of peritoneal and alveolar macrophages.
Loos M; Müller W; Boltz-Nitulescu G; Förster O
Immunobiology; 1980 Apr; 157(1):54-61. PubMed ID: 7203513
[TBL] [Abstract][Full Text] [Related]
12. C1q acts synergistically with phorbol dibutyrate to activate CR1-mediated phagocytosis by human mononuclear phagocytes.
Bobak DA; Frank MM; Tenner AJ
Eur J Immunol; 1988 Dec; 18(12):2001-7. PubMed ID: 2975599
[TBL] [Abstract][Full Text] [Related]
13. Human pulmonary surfactant protein (SP-A), a protein structurally homologous to C1q, can enhance FcR- and CR1-mediated phagocytosis.
Tenner AJ; Robinson SL; Borchelt J; Wright JR
J Biol Chem; 1989 Aug; 264(23):13923-8. PubMed ID: 2788165
[TBL] [Abstract][Full Text] [Related]
14. Reversible inhibition of C1Q release from guinea pig macrophages by 2,2'-dipyridyl: Evidence for a posttranslational hydroxylation step in the biosynthesis of C1Q, a subcomponent of the first component of complement (C1).
Müller W; Hanauske-Abel H; Loos M
FEBS Lett; 1978 Jun; 90(2):218-22. PubMed ID: 566678
[No Abstract] [Full Text] [Related]
15. Ligand inhibition studies on the role of Fc receptors in antibody-dependent cell-mediated cytotoxicity.
Sármay G; Benczur M; Petrányi G; Klein E; Kahn M; Stanworth DR; Gergely J
Mol Immunol; 1984 Jan; 21(1):43-51. PubMed ID: 6608661
[TBL] [Abstract][Full Text] [Related]
16. Antibody-mediated erythrolysis and erythrophagocytosis by human monocytes, macrophages and activated macrophages. Evidence for distinction between involvement of high-affinity and low-affinity receptors for IgG by using different erythroid target cells.
Rüegg SJ; Jungi TW
Immunology; 1988 Mar; 63(3):513-20. PubMed ID: 2965100
[TBL] [Abstract][Full Text] [Related]
17. Functional polymorphisms of Fc receptors in human monocyte-mediated cytotoxicity towards erythrocytes induced by murine isotype switch variants.
Boot JH; Geerts ME; Aarden LA
J Immunol; 1989 Feb; 142(4):1217-23. PubMed ID: 2492577
[TBL] [Abstract][Full Text] [Related]
18. C1q enhancement of antibody-dependent granulocyte-mediated killing of nonphagocytosable targets in vitro.
Hamada A; Young J; Chmielewski RA; Greene BM
J Clin Invest; 1988 Sep; 82(3):945-9. PubMed ID: 2843577
[TBL] [Abstract][Full Text] [Related]
19. Role of low-affinity Fc receptors in antibody-dependent tumor cell phagocytosis by human monocyte-derived macrophages.
Munn DH; McBride M; Cheung NK
Cancer Res; 1991 Feb; 51(4):1117-23. PubMed ID: 1825476
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
Borrok MJ; Luheshi NM; Beyaz N; Davies GC; Legg JW; Wu H; Dall'Acqua WF; Tsui P
MAbs; 2015; 7(4):743-51. PubMed ID: 25970007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
